Skip to main content
. 2020 Aug 4;18(8):411. doi: 10.3390/md18080411

Table 7.

IC50 of G6PD inhibitory activity and names of compounds in Scheme 9.

No. IC50 (μM) Names
7.3.1 76.6 ± 0.1 (a) 3,5-dibromo-4-hydroxybenzaldehyde [117]
7.3.2 4.01 ± 0.3 (a), 3,4-dibromo-5-(2-bromo-3,4-dihydroxy-6-(hydroxymethyl)benzyl)benzene-1,2-diol [117]
7.3.3 0.85 ± 0.1 (a) Bis(2,3-dibromo-4,5-dihydroxybenzyl)ether [117]
7.3.4 321 ± 18 (a) 3,4-dibromo-5-(butoxymethyl)benzene-1,2-diol [118]
7.3.5 0.97 ± 0.1 (a) Bis-(2,3,6-tribromo-4,5-dihydroxybenzyl methyl ether) [118]
7.3.6 0.85 ± 0.1 (a) 5,5’-(oxybis(methylene))bis(3,4-dibromobenzene-1,2-diol) [118]
7.3.7 0.47 ± 0.03 (a) 5,5’-methylenebis(3,4-dibromobenzene-1,2-diol) [118]
7.3.8 0.53 ± 0.18 (a) 3,4-dibromo-5-(2-bromo-3,4-dihydroxy-6-(methoxymethyl)benzyl)benzene-1,2-diol [118]

Notes: a, Leuconostoc mesenteroides G6PD; b, Saccharomyces cerevisiae G6PD.